AZZ vs GSK · P/E 14, rev $1.65B vs P/E 13, $103.31B cap
AZZ Incorporated (AZZ) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
AZZ Incorporated (AZZ) is a specialty business services company listed on NYSE.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported AZZ revenue for 2026-02-28 was $1.65B. Net income was $317.3M. Revenue was up 4.6% from 2025-02-28 to 2026-02-28. AZZ currently screens at market cap $4.56B and trailing P/E 14.5.
GSK does not have a complete income-statement cache yet.
AZZ currently screens at market cap $4.56B and trailing P/E 14.5. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the AZZ and GSK stock pages for the full models.
Not investment advice.